Drug Profile
Ethinylestradiol/levonorgestrel - MEDA Pharma
Alternative Names: EvalunaLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Meda Pharma GmbH & Co KG
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 05 Jul 2019 Chemical structure information added
- 17 Mar 2016 MEDA Pharma initiates a phase III trial for the prevention of pregnancy in Germany (EudraCT2012-004762-18)